Credit Suisse’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8.32M | Buy |
1,548,826
+18,918
| +1% | +$102K | 0.01% | 1008 |
|
|
2023
Q4 | $7.68M | Sell |
1,529,908
-4,229
| -0.3% | -$21.2K | 0.01% | 1071 |
|
|
2023
Q3 | $2.59M | Buy |
1,534,137
+517,643
| +51% | +$875K | ﹤0.01% | 1657 |
|
|
2023
Q2 | $2.83M | Buy |
1,016,494
+126,795
| +14% | +$352K | ﹤0.01% | 1682 |
|
|
2023
Q1 | $1.62M | Buy |
889,699
+199,965
| +29% | +$364K | ﹤0.01% | 1989 |
|
|
2022
Q4 | $3.5M | Sell |
689,734
-8,318
| -1% | -$42.2K | ﹤0.01% | 1530 |
|
|
2022
Q3 | $3.47M | Buy |
698,052
+9,578
| +1% | +$47.6K | ﹤0.01% | 1465 |
|
|
2022
Q2 | $2.56M | Buy |
688,474
+230,999
| +50% | +$859K | ﹤0.01% | 1725 |
|
|
2022
Q1 | $2.57M | Buy |
457,475
+26,721
| +6% | +$150K | ﹤0.01% | 1901 |
|
|
2021
Q4 | $2.62M | Buy |
430,754
+39,093
| +10% | +$238K | ﹤0.01% | 1970 |
|
|
2021
Q3 | $3.82M | Buy |
391,661
+213,636
| +120% | +$2.08M | ﹤0.01% | 1706 |
|
|
2021
Q2 | $2.54M | Sell |
178,025
-4,045
| -2% | -$57.8K | ﹤0.01% | 2025 |
|
|
2021
Q1 | $4.32M | Buy |
182,070
+20,487
| +13% | +$486K | ﹤0.01% | 1636 |
|
|
2020
Q4 | $2.15M | Buy |
161,583
+126,192
| +357% | +$1.68M | ﹤0.01% | 2080 |
|
|
2020
Q3 | $246K | Buy |
+35,391
| New | +$246K | ﹤0.01% | 3013 |
|
|
2020
Q2 | – | Sell |
-34,203
| Closed | -$99K | – | 3349 |
|
|
2020
Q1 | $99K | Sell |
34,203
-92,406
| -73% | -$267K | ﹤0.01% | 3210 |
|
|
2019
Q4 | $480K | Buy |
+126,609
| New | +$480K | ﹤0.01% | 2945 |
|
|
2018
Q3 | – | Sell |
-13,323
| Closed | -$41K | – | 3344 |
|
|
2018
Q2 | $41K | Sell |
13,323
-8,360
| -39% | -$25.7K | ﹤0.01% | 3452 |
|
|
2018
Q1 | $84K | Buy |
21,683
+8,274
| +62% | +$32.1K | ﹤0.01% | 3398 |
|
|
2017
Q4 | $60K | Sell |
13,409
-12,502
| -48% | -$55.9K | ﹤0.01% | 3398 |
|
|
2017
Q3 | $142K | Buy |
25,911
+6,740
| +35% | +$36.9K | ﹤0.01% | 3530 |
|
|
2017
Q2 | $145K | Buy |
19,171
+3,939
| +26% | +$29.8K | ﹤0.01% | 3290 |
|
|
2017
Q1 | $54K | Sell |
15,232
-9,488
| -38% | -$33.6K | ﹤0.01% | 3369 |
|
|
2016
Q4 | $142K | Sell |
24,720
-1,462
| -6% | -$8.4K | ﹤0.01% | 3530 |
|
|
2016
Q3 | $204K | Sell |
26,182
-14,165
| -35% | -$110K | ﹤0.01% | 3466 |
|
|
2016
Q2 | $250K | Buy |
40,347
+24,825
| +160% | +$154K | ﹤0.01% | 3465 |
|
|
2016
Q1 | $127K | Buy |
15,522
+1,900
| +14% | +$15.5K | ﹤0.01% | 3484 |
|
|
2015
Q4 | $236K | Buy |
13,622
+2,667
| +24% | +$46.2K | ﹤0.01% | 3585 |
|
|
2015
Q3 | $125K | Buy |
+10,955
| New | +$125K | ﹤0.01% | 3849 |
|